Resultados de la búsqueda 241-250 of 7553 for Drug

  1. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast ...

  2. Dermatología - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However ...

  4. Oncología (médica) - Ensayos clínicos

    The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However ...

  5. Ensayos clínicos - Dermatología

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  6. Dermatología - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This research is being done to evaluate the safety and tolerability of the new drug ... drugs for diagnosing and treating aggressive tumor ...

  8. Zinc - Mayo Clinic

    Zinc oxide: Drug information (Óxido de zinc: información sobre el medicamento). https://www.uptodate.com/contents/search. Último acceso: 8 de agosto de 2017 ...

  9. Ensayos clínicos - Dermatología

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...

  10. Dermatología - Ensayos clínicos

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...